Literature DB >> 23934388

Perspectives of the relationship between IL-7 and autoimmune diseases.

Xiao-Song Wang1, Bao-Zhu Li, Lin-Feng Hu, Peng-Fei Wen, Min Zhang, Hai-Feng Pan, Dong-Qing Ye.   

Abstract

Interleukin (IL)-7 is one of the IL-2 family cytokines comprised of IL-2, IL-4, IL-7, IL-9, IL-15, as well as IL-21. IL-7 is mainly secreted by stroma cells in primary lymphoid tissues, playing an essential role in the program of T cell development. Recently, studies have revealed that physiological function exerted by immunocytes can be influenced by aberrant IL-7 signaling, which is common in abnormal autoimmunity regulation. There is also increasing evidence that IL-7 is involved in several autoimmune diseases, such as rheumatoid arthritis, type I diabetes, multiple sclerosis and systemic lupus erythematosus, etc. Targeting components in IL-7 signaling pathways may have potential significance for treating numerous autoimmune diseases. In this review, we therefore summarize our current understandings regarding the relationship between IL-7 and autoimmune diseases so as to render more valuable information on this kind of research.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23934388     DOI: 10.1007/s10067-013-2360-x

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  69 in total

Review 1.  Interleukin-7: from bench to clinic.

Authors:  Terry J Fry; Crystal L Mackall
Journal:  Blood       Date:  2002-06-01       Impact factor: 22.113

2.  Interleukin (IL)-7 induces rapid activation of Pyk2, which is bound to Janus kinase 1 and IL-7Ralpha.

Authors:  N Benbernou; K Muegge; S K Durum
Journal:  J Biol Chem       Date:  2000-03-10       Impact factor: 5.157

3.  Protein microarray analysis of disease activity in pediatric inflammatory bowel disease demonstrates elevated serum PLGF, IL-7, TGF-beta1, and IL-12p40 levels in Crohn's disease and ulcerative colitis patients in remission versus active disease.

Authors:  Howard A Kader; Velizar T Tchernev; Ebenezer Satyaraj; Serguei Lejnine; Gregory Kotler; Stephen F Kingsmore; Dhavalkumar D Patel
Journal:  Am J Gastroenterol       Date:  2005-02       Impact factor: 10.864

4.  Increased IL-7 expression in Vogt-Koyanagi-Harada disease.

Authors:  Yan Yang; Xiang Xiao; Fuzhen Li; Liping Du; Aize Kijlstra; Peizeng Yang
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-02-27       Impact factor: 4.799

5.  Interleukin-7: a key mediator in T cell-driven autoimmunity, inflammation, and tissue destruction.

Authors:  Angela Bikker; C Erik Hack; Floris P J G Lafeber; Joel A G van Roon
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

6.  Soluble IL7Rα potentiates IL-7 bioactivity and promotes autoimmunity.

Authors:  Wangko Lundström; Steven Highfill; Scott T R Walsh; Stephanie Beq; Elizabeth Morse; Ingrid Kockum; Lars Alfredsson; Tomas Olsson; Jan Hillert; Crystal L Mackall
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-22       Impact factor: 11.205

Review 7.  Understanding the epidemiology and progression of systemic lupus erythematosus.

Authors:  Guillermo J Pons-Estel; Graciela S Alarcón; Lacie Scofield; Leslie Reinlib; Glinda S Cooper
Journal:  Semin Arthritis Rheum       Date:  2009-01-10       Impact factor: 5.532

8.  Limiting {gamma}c expression differentially affects signaling via the interleukin (IL)-7 and IL-15 receptors.

Authors:  Christine M Smyth; Samantha L Ginn; Claire T Deakin; Grant J Logan; Ian E Alexander
Journal:  Blood       Date:  2007-03-15       Impact factor: 22.113

Review 9.  Inflammatory cytokines in systemic lupus erythematosus.

Authors:  Kim Ohl; Klaus Tenbrock
Journal:  J Biomed Biotechnol       Date:  2011-10-16

10.  Autoimmune arthritis associated with mutated interleukin (IL)-6 receptor gp130 is driven by STAT3/IL-7-dependent homeostatic proliferation of CD4+ T cells.

Authors:  Shin-ichiro Sawa; Daisuke Kamimura; Gui-Hua Jin; Hideyuki Morikawa; Hokuto Kamon; Mika Nishihara; Katsuhiko Ishihara; Masaaki Murakami; Toshio Hirano
Journal:  J Exp Med       Date:  2006-05-22       Impact factor: 14.307

View more
  8 in total

1.  Variable neuroendocrine-immune dysfunction in individuals with unfavorable outcome after severe traumatic brain injury.

Authors:  M Santarsieri; R G Kumar; P M Kochanek; S Berga; A K Wagner
Journal:  Brain Behav Immun       Date:  2014-09-16       Impact factor: 7.217

Review 2.  Breaking Free of Control: How Conventional T Cells Overcome Regulatory T Cell Suppression.

Authors:  Emily R Mercadante; Ulrike M Lorenz
Journal:  Front Immunol       Date:  2016-05-18       Impact factor: 7.561

Review 3.  Is Graves' disease a primary immunodeficiency? New immunological perspectives on an endocrine disease.

Authors:  Tristan Struja; Alexander Kutz; Stefan Fischli; Christian Meier; Beat Mueller; Mike Recher; Philipp Schuetz
Journal:  BMC Med       Date:  2017-09-25       Impact factor: 8.775

4.  Characterization of the robust humoral immune response to GSK2618960, a humanized anti-IL-7 receptor monoclonal antibody, observed in healthy subjects in a Phase 1 study.

Authors:  Karen Liao; Keguan Chen; Sara Brett; Andrew Gehman; Ann M Schwartz; George R Gunn; Stephen L DeWall
Journal:  PLoS One       Date:  2021-03-23       Impact factor: 3.240

Review 5.  Clinical biomarkers and pathogenic-related cytokines in rheumatoid arthritis.

Authors:  Xiaoyin Niu; Guangjie Chen
Journal:  J Immunol Res       Date:  2014-08-21       Impact factor: 4.818

6.  Correlation of Serum Soluble Interleukin-7 Receptor and Anti-C1q Antibody in Patients with Systemic Lupus Erythematosus.

Authors:  Shuhong Chi; Jing Xue; Feng Li; Caixia Zhu; Yunxia Yu; Haibo Li; Xuemei Wang; Yurong Zhang; Jijuan Yang; Shaolan Zhou; Lijuan Yang; Chen Ji; Xiaoming Liu
Journal:  Autoimmune Dis       Date:  2016-03-16

7.  Interleukin-7 in Patients With Chronic Hepatitis B May Have Effect on T Follicular Helper Cells and Specific Cellular Immunity.

Authors:  Hua Zhong; Gu Xibing; Dai Yaping; Wang Zheng; Fu Decai; Guo Xiaoye; Wu Hangyuan; Wang Dong; Lu Zhonghua
Journal:  Hepat Mon       Date:  2016-08-15       Impact factor: 0.660

8.  Integrative analysis of miRNA-mRNA network in high altitude retinopathy by bioinformatics analysis.

Authors:  Tong Su; Chufeng Gu; Deji Draga; Chuandi Zhou; Thashi Lhamo; Zhi Zheng; Qinghua Qiu
Journal:  Biosci Rep       Date:  2021-01-29       Impact factor: 3.840

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.